Correlation Between Apple and CRISPR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apple and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apple and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apple Inc and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Apple and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apple with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apple and CRISPR Therapeutics.
Diversification Opportunities for Apple and CRISPR Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Apple and CRISPR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apple Inc and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Apple is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apple Inc are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Apple i.e., Apple and CRISPR Therapeutics go up and down completely randomly.
Pair Corralation between Apple and CRISPR Therapeutics
If you would invest 14,006 in Apple Inc on October 30, 2024 and sell it today you would earn a total of 8,044 from holding Apple Inc or generate 57.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apple Inc vs. CRISPR Therapeutics AG
Performance |
| Timeline |
| Apple Inc |
| CRISPR Therapeutics |
Apple and CRISPR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apple and CRISPR Therapeutics
The main advantage of trading using opposite Apple and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apple position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.| Apple vs. UNITED RENTALS | Apple vs. Ameriprise Financial | Apple vs. PNC Financial Services | Apple vs. BANK OF CHINA |
| CRISPR Therapeutics vs. CeoTronics AG | CRISPR Therapeutics vs. Coor Service Management | CRISPR Therapeutics vs. LANDSEA GREEN MANAGEMENT | CRISPR Therapeutics vs. Platinum Investment Management |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |